Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other financing activities (2024)

Abeona Therapeutics has reported Other financing activities over the past 5 years, most recently at $963000.0 for Q1 2024.

  • Quarterly results put Other financing activities at $963000.0 for Q1 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $963000.0 (changed N/A YoY), and the annual figure for FY2024 was $963000.0, up 542.0%.
  • Other financing activities for Q1 2024 was $963000.0 at Abeona Therapeutics, up from -$2.9 million in the prior quarter.
  • Over the last five years, Other financing activities for ABEO hit a ceiling of $963000.0 in Q1 2024 and a floor of $963000.0 in Q1 2024.